TCWM
SGMO

Total Clarity Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Total Clarity Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-125
Closed -$1K – 521
2019
Q4 		$1K Buy
+125
New +$1.15K ﹤0.01% 676

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Total Clarity Wealth Management's SGMO Position: Q1 2020 in Review

Total Clarity Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2020, closing a stake of 125 shares — an estimated $1K sold.

Total Clarity Wealth Management first reported a position in SGMO in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Total Clarity Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2020 after selling out during the quarter.
  • Total Clarity Wealth Management sold 125 SANGAMO THERAPEUTICS INC shares in Q1 2020, an estimated $1K.
  • Total Clarity Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2019 and held it in 1 quarter.
  • Total Clarity Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $1K in Q4 2019.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Total Clarity Wealth Management's 13F filing for Q1 2020, filed 24 Apr 2020.